This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Attention to artificial openings
Z21_ATTN_ARTIF_OPENI
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1429 |
4. Check minimum number of eventsNone |
1429 |
5. Include endpointsNone |
1429 |
6. Filter based on genotype QC (FinnGen only) |
1429 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Attention to artificial openings
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1429 | 505 | 924 |
| Unadjusted period prevalence (%) | 0.32 | 0.17 | 0.41 |
| Median age at first event (years) | 69.02 | 64.77 | 71.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1238
- Matched controls
- 12379
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z43.5
ICD-10 Finland
Attention to cystostomy
1239.7
323.0
415
5
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
50.4
323.0
414
122
Z43.3
ICD-10 Finland
Attention to colostomy
+∞
256.3
237
*
Z43.2
ICD-10 Finland
Attention to ileostomy
+∞
222.8
207
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
48.7
198.1
241
61
R33
ICD-10 Finland
Retention of urine
9.8
193.6
443
665
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
191.7
179
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
+∞
179.6
168
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
60.5
170.3
199
39
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
68.6
167.6
192
33
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
16.6
123.5
205
146
Z51.5
ICD-10 Finland
Palliative care
33.1
122.3
162
56
ZX120
NOMESCO Finland
Intravenous
7.8
121.8
311
511
Z71.8
ICD-10 Finland
Other specified counselling
4.9
119.4
497
1499
N02AA05
ATC
oxycodone; systemic
6.0
119.0
379
841
TJD20
NOMESCO Finland
Change of gastrostomy tube
137.5
117.4
124
10
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
16.9
116.1
191
132
130
Kela drug reimbursment
Malignant tumour
7.6
113.6
292
480
R4190
NOMESCO Finland
Nutritional therapy
18.2
109.6
175
111
Z3231
NOMESCO Finland
Registered nurse
4.2
108.1
559
2038
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.5
107.6
374
907
GBB00
NOMESCO Finland
Tracheostomy
34.4
107.6
141
46
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
44.9
104.5
129
32
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
6.9
103.0
285
515
RD211
NOMESCO Finland
NA
12.5
102.7
193
180
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
102.5
97
*
TKC20
NOMESCO Finland
Catheterisation of bladder
7.0
100.5
272
475
A28
ICPC
Limited function/disability NOS
4.8
98.2
388
1069
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.1
93.5
345
877
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
15.0
90.2
155
117
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
89.8
397
1207
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
+∞
89.7
85
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.9
86.2
234
404
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
39.3
85.2
108
30
J01MA02
ATC
ciprofloxacin; systemic
3.2
82.4
679
3374
TQW40
NOMESCO Finland
Remowal of suture of skin
6.9
80.3
218
374
N30.0
ICD-10 Finland
Acute cystitis
4.8
78.7
301
778
WZC30
NOMESCO Finland
Teaching
4.6
78.4
310
829
SPAT1262
SPAT
Handing over of treatment supplies
3.8
75.3
400
1395
Z93.5
ICD-10 Finland
Cystostomy status
204.9
75.1
77
*
B01AB05
ATC
enoxaparin; parenteral
3.2
71.0
512
2241
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
70.5
268
681
SPAT1125
SPAT
Stoma care and guidance
21.7
70.0
104
52
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
69.8
342
1104
UKC02
NOMESCO Finland
Cystoscopy
3.5
67.1
392
1456
L01BC06
ATC
capecitabine; oral
9.9
66.7
140
158
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
66.0
478
2071
JAH00
NOMESCO Finland
Laparotomy
10.0
64.8
135
150
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
660.8
64.5
63
*
J01EA01
ATC
trimethoprim; systemic
3.3
63.8
410
1625
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.5
62.7
247
644
ZXD05
NOMESCO Finland
Urgent procedure
2.9
62.1
512
2398
R4110
NOMESCO Finland
Physiotherapy
3.1
61.8
435
1831
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
61.6
498
2299
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
59.6
338
1209
SPAT1167
SPAT
Insertion of urinary catheter
7.7
59.6
146
212
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
6.2
58.9
169
306
U07
ICPC
Urine symptom/complaint other
6.1
55.2
161
297
XX1AD
NOMESCO Finland
Other CT-examination
561.6
55.0
54
*
R31
ICD-10 Finland
Unspecified haematuria
3.8
54.3
266
838
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.9
53.7
161
307
KCJ00
NOMESCO Finland
Cystostomy
282.7
53.6
54
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
54.2
52.3
62
12
U05
ICPC
Urination problems other
6.1
52.2
152
279
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
24.9
51.6
73
31
R13
ICD-10 Finland
Dysphagia
5.3
51.5
170
363
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.1
51.4
112
134
WF001
NOMESCO Finland
Preoperative radiotherapy
21.2
51.1
76
38
A06AD11
ATC
lactulose; oral
3.3
50.7
298
1078
-1
NOMESCO Finland
NA
2.7
50.5
460
2219
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.9
50.0
119
164
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
11.2
48.6
94
90
U08
ICPC
Urinary retention
9.8
48.6
101
111
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.8
48.6
175
410
N30.9
ICD-10 Finland
Cystitis, unspecified
6.1
47.8
138
250
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
47.6
204
566
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
33.7
46.8
61
19
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.8
46.6
167
388
GBB13
NOMESCO Finland
Revision of tracheostomy
474.6
46.6
46
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
31.0
46.6
62
21
U29
ICPC
Urinary symptom/complaint other
8.9
46.3
102
124
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
11.3
45.8
88
83
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.0
44.5
298
1169
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.4
44.5
123
210
UJF32
NOMESCO Finland
Coloscopy
2.6
44.5
420
2038
TJF80
NOMESCO Finland
Ostomy education
18.9
44.1
68
38
M03BX01
ATC
baclofen; systemic
15.1
43.5
73
51
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
46.0
43.5
53
12
R50.9
ICD-10 Finland
Fever, unspecified
3.2
42.8
256
926
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
10.0
42.4
87
93
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
42.0
446
2290
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.2
41.8
170
447
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.6
41.4
384
1830
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
25.3
41.3
58
24
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.0
40.7
95
127
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.6
40.6
125
244
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.3
40.6
130
266
JFF10
NOMESCO Finland
Loop enterostomy
23.3
40.4
58
26
L89
ICD-10 Finland
Decubitus ulcer and pressure area
10.2
39.7
80
83
U28
ICPC
Limited function/disability (U)
18.8
39.6
61
34
L28
ICPC
Limited function/disability (L)
3.0
39.5
264
1024
RD210
NOMESCO Finland
NA
16.0
39.1
64
42
ZX080
NOMESCO Finland
Image guided radiotherapy
12.7
38.8
70
58
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
38.3
318
1410
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.0
38.3
83
98
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
38.2
388
1925
J01MA12
ATC
levofloxacin; systemic
2.7
38.1
322
1443
C03CA01
ATC
furosemide; systemic
2.3
37.5
475
2630
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
37.4
281
1170
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.1
37.4
155
413
Z50.1
ICD-10 Finland
Other physical therapy
14.0
37.0
64
48
SPAT1171
SPAT
Bladder puncture
62.0
36.3
42
7
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
130.5
35.9
38
*
ZYC01
NOMESCO Finland
Remote contact by phone
6.0
35.7
103
185
Z25.1
ICD-10 Finland
Need for immunization against influenza
4.7
35.6
129
301
U13
ICPC
Bladder symptom/complaint other
7.7
35.2
84
116
Z00.0
ICD-10 Finland
General medical examination
2.6
35.0
305
1384
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
34.4
244
976
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.3
33.5
92
155
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
17.2
33.5
53
32
Z3226
NOMESCO Finland
Physiotherapist
2.7
33.4
275
1202
A04AA01
ATC
ondansetron; systemic, rectal
4.8
33.2
117
265
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
32.9
147
417
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.5
32.9
65
65
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.9
32.8
84
129
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
32.7
238
965
J01DB01
ATC
cefalexin; oral
2.3
32.7
991
7863
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
32.4
31
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
32.3
428
2383
R39.1
ICD-10 Finland
Other difficulties with micturition
6.2
32.3
90
155
SPAT1229
SPAT
Assessment of need for aid
3.6
32.2
159
490
N03AX16
ATC
pregabalin; oral
2.4
32.2
326
1593
JFF23
NOMESCO Finland
Transversostomy
13.6
32.1
56
43
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
18.8
32.0
49
27
N02BE01
ATC
paracetamol; systemic, rectal
2.4
31.9
1043
8519
GBB96
NOMESCO Finland
Other tracheostomy procedure
116.4
31.8
34
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
7.8
31.5
74
100
AN2
HP
Balloon angioplasty, including several vessels
6.2
31.3
87
149
R5110
SPAT
NA
7.4
31.3
76
108
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.5
31.1
116
278
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
8.5
31.1
69
85
R53
ICD-10 Finland
Malaise and fatigue
2.4
30.8
299
1424
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.8
30.8
80
125
SPAT1216
SPAT
Assessment of functional ability
2.6
30.4
253
1107
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
+∞
30.3
29
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
30.0
439
2534
K59.09
ICD-10 Finland
Constipation, unspecified
3.9
30.0
131
364
WX892
NOMESCO Finland
Monitored bed care
3.5
29.9
149
462
R11
ICD-10 Finland
Nausea and vomiting
3.7
29.7
139
410
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
29.2
200
777
E86
ICD-10 Finland
Volume depletion
6.5
29.0
77
124
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
28.9
236
1018
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
16.4
28.6
46
29
A04AA02
ATC
granisetron; systemic, transdermal
4.6
28.5
103
239
Z43.8
ICD-10 Finland
Attention to other artificial openings
+∞
28.2
27
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
28.2
183
686
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
27.9
28.1
38
14
TGB20
NOMESCO Finland
Tracheostomy tube replacement
148.2
27.7
29
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
27.6
153
512
Z50.5
ICD-10 Finland
Speech therapy
17.8
27.6
43
25
ZX121
NOMESCO Finland
Central venous catheter
35.9
27.5
35
10
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.4
27.3
73
119
N18
ICPC
Paralysis/weakness
7.6
27.2
65
90
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
27.2
26
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
18.1
27.1
42
24
JDB00
NOMESCO Finland
Gastrostomy
63.5
27.0
31
5
KC1AT
NOMESCO Finland
Puncture of urinary bladder with ultrasound guidance
63.5
27.0
31
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.2
26.9
108
278
JN4BD
NOMESCO Finland
Extensive body CT
2.9
26.9
182
700
B01AB10
ATC
tinzaparin; parenteral
3.7
26.8
122
351
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
6.0
26.8
76
134
SPAT1301
SPAT
No procedures
2.0
26.8
437
2612
H02AB02
ATC
dexamethasone; systemic
3.2
26.7
149
502
A41.9
ICD-10 Finland
Sepsis, unspecified
5.1
26.7
87
181
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
26.6
120
342
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
9.8
26.6
54
57
Z93.3
ICD-10 Finland
Colostomy status
15.2
26.6
44
30
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
26.2
181
702
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
61.4
26.1
30
5
XKD00
NOMESCO Finland
Uroflowmetry
2.2
25.7
311
1629
Z2446
NOMESCO Finland
Social worker
3.9
25.5
110
302
SPAT1252
SPAT
Overall medication plan or its review
3.3
25.4
139
462
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
25.4
257
1238
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
25.4
233
1065
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
25.2
65
101
R4120
NOMESCO Finland
Occupational therapy
3.9
24.8
106
288
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
12.6
24.7
44
36
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
24.6
119
359
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
9.3
24.4
51
57
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
9.3
24.4
51
57
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
24.2
203
882
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.5
24.0
118
361
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.2
23.6
134
457
SPAT1255
SPAT
Intravenous administration of medicine
3.4
23.6
121
383
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
23.4
259
1295
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.8
23.4
104
293
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
23.2
164
643
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
23.1
168
672
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
55.1
23.1
27
5
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.3
23.0
89
221
U04
ICPC
Incontinence urine
4.1
23.0
92
236
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.8
22.7
99
274
TKC10
SPAT
NA
234.0
22.7
23
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
22.6
285
1512
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
22.5
385
2312
Z93.2
ICD-10 Finland
Ileostomy status
32.9
22.5
29
9
J01CA08
ATC
pivmecillinam; oral
2.0
22.2
369
2187
SPAT1254
SPAT
Administration of medicine
2.4
22.1
218
1028
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.0
21.8
71
148
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
11.1
21.7
41
38
TKC22
NOMESCO Finland
Catheterisation instruction
5.2
21.5
68
137
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
10.3
21.4
42
42
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
23.6
21.3
30
13
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
15.0
21.2
35
24
N06AX11
ATC
mirtazapine; oral
1.9
21.2
363
2171
K65.0
ICD-10 Finland
Acute peritonitis
9.6
21.2
43
46
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.3
21.1
80
195
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.4
21.1
56
91
Z43.9
ICD-10 Finland
Attention to unspecified artificial opening
+∞
20.9
20
*
WW500
NOMESCO Finland
Blood transfusion
4.6
20.8
73
165
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
11.1
20.7
39
36
U99
ICPC
Urinary disease other
13.2
20.7
36
28
R4130
NOMESCO Finland
Speech therapy
7.3
20.7
50
71
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.7
20.7
94
270
A04AA55
ATC
palonosetron, combinations; systemic
6.5
20.7
54
86
Z93.0
ICD-10 Finland
Tracheostomy status
213.3
20.6
21
*
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
11.5
20.5
38
34
D21
ICPC
Swallowing problem
9.0
20.4
43
49
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
4.4
20.3
76
183
A02BC02
ATC
pantoprazole; systemic
1.8
20.2
759
5856
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.8
20.2
87
239
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
20.1
451
2953
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
17.6
20.1
31
18
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
19.2
20.0
30
16
TQW99
NOMESCO Finland
Other minor procedure on skin
3.6
19.9
94
278
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.2
19.9
77
192
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.7
19.8
90
258
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
19.8
241
1247
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
15.6
19.8
32
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.4
19.5
43
53
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.6
19.4
158
670
UJC01
NOMESCO Finland
Scopy of lower throat
10.3
19.4
38
38
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
31.8
19.3
25
8
S97
ICPC
Chronic ulcer skin
3.4
19.3
98
308
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.1
19.2
76
193
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
46.8
19.2
23
5
UGB02
NOMESCO Finland
Tracheoscopy
46.8
19.2
23
5
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.5
19.2
57
107
L03AA02
ATC
filgrastim; parenteral
6.0
19.2
53
91
WX402
NOMESCO Finland
General anaesthesia
2.2
19.2
208
1022
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
10.0
19.2
38
39
K90
ICPC
Stroke/cerebrovascular accident
4.6
19.0
66
148
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
15.1
19.0
31
21
T81.9
ICD-10 Finland
Unspecified complication of procedure
6.9
18.9
47
70
N03AG01
ATC
valproic acid; systemic, rectal
3.4
18.9
93
285
ZX112
NOMESCO Finland
Subcutaneous
5.9
18.9
53
93
Z43.4
ICD-10 Finland
Attention to other artificial openings of digestive tract
+∞
18.8
18
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
18.7
210
1049
WF004
NOMESCO Finland
Palliative radiotherapy
7.8
18.7
43
57
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
101.5
18.6
20
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.1
18.3
73
187
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.9
18.3
51
89
TK800
NOMESCO Finland
Hemodialysis
9.5
18.2
37
40
WX730
NOMESCO Finland
Conventional respirator
6.3
18.0
48
79
T05
ICPC
Feeding problem of adult
13.2
18.0
31
24
J96.1
ICD-10 Finland
Chronic respiratory failure
5.2
17.9
56
112
G82.5
ICD-10 Finland
Tetraplegia, unspecified
67.6
17.8
20
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
14.8
17.7
29
20
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.4
17.6
46
74
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
7.5
17.5
41
56
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
17.5
199
996
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
17.5
233
1250
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.6
17.5
81
237
AA1AD
NOMESCO Finland
CT of head and brain
1.9
17.3
315
1902
Z46.6
ICD-10 Finland
Fitting and adjustment of urinary device
42.6
17.3
21
5
G04CA02
ATC
tamsulosin; oral
1.8
17.2
403
2648
JAH01
NOMESCO Finland
Laparoscopy
4.0
17.1
70
184
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.4
17.1
45
73
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.9
17.0
108
396
J96.0
ICD-10 Finland
Acute respiratory failure
7.7
17.0
39
52
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
10.2
17.0
33
33
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
8.0
16.9
38
49
K56.7
ICD-10 Finland
Ileus, unspecified
6.0
16.7
46
79
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.0
16.7
35
40
JFF24
NOMESCO Finland
Laparoscopic transversostomy
91.3
16.6
18
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.6
16.6
132
552
N28
ICPC
Limited function/disability (N)
7.4
16.6
39
54
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
172.1
16.5
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.8
16.2
54
116
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.9
16.1
45
79
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
11.8
16.1
29
25
SPAT1234
SPAT
Support of social functional capacity
3.3
16.1
84
270
UJC12
NOMESCO Finland
Flexible oesophagoscopy
10.9
16.0
30
28
XJH00
NOMESCO Finland
Transanal ultrasonography
2.5
16.0
132
565
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.1
16.0
33
37
A46
ICD-10 Finland
Erysipelas
2.1
15.9
193
993
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
7.2
15.9
38
54
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
14.7
15.9
26
18
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.3
15.8
81
257
N05BA01
ATC
diazepam; systemic, rectal
2.2
15.8
179
895
J01XX05
ATC
methenamine; oral
9.3
15.7
32
35
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
15.7
146
664
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.8
15.6
39
59
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
86.1
15.6
17
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
86.1
15.6
17
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
15.6
94
333
R1250
NOMESCO Finland
Evaluation of functional capability
6.1
15.5
42
71
N03AX14
ATC
levetiracetam; systemic
4.8
15.5
52
113
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.0
15.4
62
161
N19
ICD-10 Finland
Unspecified kidney failure
3.7
15.4
68
192
N03AE01
ATC
clonazepam; systemic
3.0
15.3
89
309
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
15.2
205
1098
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.4
15.2
45
85
R15
ICD-10 Finland
Faecal incontinence
5.0
15.2
48
98
K22.2
ICD-10 Finland
Oesophageal obstruction
7.9
15.1
34
44
P01AB01
ATC
metronidazole; oral, rectal
1.7
15.1
413
2815
109
Kela drug reimbursment
Multiple sclerosis
14.1
15.0
25
18
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.7
15.0
43
78
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.1
15.0
86
295
L04AX01
ATC
azathioprine; systemic
3.4
15.0
74
228
N05CF01
ATC
zopiclone; oral
1.7
14.9
387
2596
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.6
14.9
52
118
G04BD08
ATC
solifenacin; oral
2.7
14.8
103
400
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
11.5
14.8
27
24
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
14.8
84
286
N05AH04
ATC
quetiapine; oral
2.1
14.8
184
954
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.8
14.7
49
106
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
7.2
14.6
35
50
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
14.6
368
2445
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.1
14.6
82
275
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.2
14.6
39
65
G35
ICD-10 Finland
Multiple sclerosis
8.2
14.6
32
40
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.6
14.5
31
37
A04
ICPC
Weakness/tiredness general
2.2
14.5
155
753
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
151.6
14.5
15
*
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
15.6
14.4
23
15
WZA10
NOMESCO Finland
Long statement of health and health related matters
7.2
14.3
34
48
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.9
14.3
59
157
SPAT1131
SPAT
Colonoscopy
3.7
14.3
63
178
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
14.2
72
227
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
43.0
14.1
17
*
SPAT1168
SPAT
Catheterisation training
12.1
14.1
25
21
WX002
NOMESCO Finland
Sedation and analgesia
1.9
14.1
232
1339
R06.0
ICD-10 Finland
Dyspnoea
1.8
14.1
303
1915
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
14.0
43
85
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
4.5
14.0
49
112
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
13.9
110
458
UJG02
NOMESCO Finland
Proctoscopy
4.8
13.9
46
99
JFH10
NOMESCO Finland
Total colectomy and ileostomy
30.4
13.9
18
6
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
20.3
13.8
20
10
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.0
13.7
37
63
N05BA06
ATC
lorazepam; systemic, sublingual
2.9
13.6
83
296
WX600
NOMESCO Finland
Single shot through catheter
6.7
13.6
34
52
TJF00
NOMESCO Finland
Insertion of jejunal tube
75.9
13.6
15
*
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
75.9
13.6
15
*
N86
ICPC
Multiple sclerosis
14.9
13.6
22
15
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
13.6
13
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.0
13.5
78
269
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.1
13.5
77
263
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
141.4
13.5
14
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.0
13.4
23
18
Z97.4
ICD-10 Finland
Presence of external hearing-aid
4.3
13.4
49
117
N05BA04
ATC
oxazepam; oral
1.8
13.4
276
1719
JFF13
NOMESCO Finland
Terminal enterostomy
21.4
13.3
19
9
Z29.0
ICD-10 Finland
Isolation
21.4
13.3
19
9
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
21.4
13.3
19
9
WX872
NOMESCO Finland
Intensive care
2.9
13.3
81
289
Z2221
NOMESCO Finland
Medical doctor
1.7
13.3
315
2046
WX882
NOMESCO Finland
High dependency care
3.7
13.2
58
163
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
13.2
159
812
K08.3
ICD-10 Finland
Retained dental root
2.6
13.2
100
408
JFB00
NOMESCO Finland
Partial resection of small intestine
5.6
13.2
38
70
K92.1
ICD-10 Finland
Melaena
2.7
13.2
89
339
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
13.1
146
722
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.0
13.1
29
37
A04AD12
ATC
aprepitant; systemic
6.3
13.1
34
55
Z00.8
ICD-10 Finland
Other general examinations
2.6
13.1
97
392
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.8
13.0
32
48
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
13.0
74
253
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
28.7
13.0
17
6
RK320
NOMESCO Finland
NA
13.1
12.9
22
17
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
5.6
12.9
37
68
RD160
NOMESCO Finland
NA
50.5
12.9
15
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.9
12.8
53
142
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
12.8
59
173
R60.0
ICD-10 Finland
Localized oedema
2.2
12.8
143
706
T90.5
ICD-10 Finland
Sequelae of intracranial injury
7.3
12.8
30
42
Z73.6
ICD-10 Finland
Limitation of activities due to disability
9.8
12.7
25
26
XKC03
NOMESCO Finland
Water cystometry
4.1
12.7
49
123
ZXE00
NOMESCO Finland
One hour or less
1.6
12.7
435
3121
U71
ICPC
Cystitis/urinary infection other
3.1
12.7
70
235
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.8
12.6
35
62
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
12.5
156
807
B03XA02
ATC
darbepoetin alfa; parenteral
6.7
12.5
31
47
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.1
12.5
39
79
N05AX08
ATC
risperidone; systemic
2.4
12.5
113
506
D75
ICPC
Malignant neoplasm colon/rectum
8.8
12.5
26
30
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.8
12.5
26
30
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.9
12.5
51
135
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
24.6
12.5
17
7
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
12.4
95
389
WF002
NOMESCO Finland
Radical radiotherapy
2.8
12.4
82
310
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
6.6
12.4
31
48
E87.6
ICD-10 Finland
Hypokalaemia
3.7
12.3
53
147
K51.5
ICD-10 Finland
Left sided colitis
4.4
12.3
44
103
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
7.2
12.3
29
41
K22.3
ICD-10 Finland
Perforation of oesophagus
37.9
12.2
15
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
37.9
12.2
15
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
12.2
75
270
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
16.0
12.1
19
12
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.1
12.1
47
119
K59.0
ICD-10 Finland
Constipation
2.6
12.1
87
345
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
12.1
123
584
ZXA05
NOMESCO Finland
Left side
1.7
12.1
297
1944
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.4
12.1
100
430
L03AA13
ATC
pegfilgrastim; parenteral
4.0
12.0
48
125
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
4.8
12.0
39
83
A11CC03
ATC
alfacalcidol; systemic
5.4
12.0
35
66
ZY010
NOMESCO Finland
Hospital outpatient
3.3
12.0
61
194
KA3EB
NOMESCO Finland
Antegrade pyelography
13.5
12.0
20
15
ZXA00
NOMESCO Finland
Right side
1.7
11.9
311
2068
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
47.1
11.9
14
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
47.1
11.9
14
*
F05.9
ICD-10 Finland
Delirium, unspecified
4.2
11.9
44
107
N05AH03
ATC
olanzapine; systemic
2.8
11.9
75
276
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.6
11.9
52
147
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
11.8
11.8
21
18
TQW80
NOMESCO Finland
Local dermatologic skincare
3.9
11.8
48
127
128
Kela drug reimbursment
Cancers of female genital organs
8.5
11.8
25
30
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
8.5
11.8
25
30
GD1LA
NOMESCO Finland
GD
14.8
11.8
19
13
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.7
476
3543
C20
ICD-10 Finland
Malignant neoplasm of rectum
7.4
11.7
27
37
S15
ICPC
Foreign body in skin
2.7
11.7
81
314
N99
ICPC
Neurological disease other
7.8
11.7
26
34
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.5
11.6
54
160
A41.8
ICD-10 Finland
Other specified sepsis
5.0
11.6
36
73
SPAT1263
SPAT
Sampling
1.6
11.6
466
3456
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
9.3
11.5
23
25
D17
ICPC
Incontinence of bowel
9.3
11.5
23
25
KCD02
NOMESCO Finland
Transurethral resection of bladder
3.4
11.5
55
167
Z49.0
ICD-10 Finland
Preparatory care for dialysis
+∞
11.5
11
*
S18
ICPC
Laceration/cut
1.5
11.5
479
3585
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
13.8
11.5
19
14
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
13.8
11.5
19
14
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
11.4
140
719
J95.0
ICD-10 Finland
Tracheostomy malfunction
121.0
11.4
12
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
11.4
87
358
Z51.88
ICD-10 Finland
Other specified medical care
5.9
11.4
31
54
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
11.9
11.3
20
17
A06AH03
ATC
naloxegol; oral
11.9
11.3
20
17
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.3
11.3
41
98
N03AX12
ATC
gabapentin; oral
1.9
11.3
170
948
602
Kela drug reimbursment
Children's severe malnutrition
35.3
11.3
14
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
9.7
11.3
22
23
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
11.3
97
425
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
17.2
11.2
17
10
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
20.2
11.1
16
8
N30
ICD-10 Finland
Cystitis
2.6
11.1
81
324
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.0
11.0
63
216
ZZA00
NOMESCO Finland
Split skin graft
3.5
11.0
51
151
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
11.0
192
1124
H02AB06
ATC
prednisolone; systemic
1.5
10.9
531
4100
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
10.8
57
186
J02AC01
ATC
fluconazole; systemic
1.6
10.8
345
2411
ZX100
NOMESCO Finland
Oral
5.7
10.7
30
54
V03AF03
ATC
calcium folinate; systemic
18.0
10.7
16
9
N18.0
ICD-10 Finland
End-stage renal disease
18.0
10.7
16
9
J01MA14
ATC
moxifloxacin; systemic
2.2
10.7
113
543
R5599
NOMESCO Finland
Other rehabilitation service
4.4
10.7
38
89
TK810
NOMESCO Finland
Hemofiltration
21.7
10.7
15
7
WX610
NOMESCO Finland
Patient controlled analgesia
21.7
10.7
15
7
R10.0
ICD-10 Finland
Acute abdomen
3.7
10.7
46
129
X57
ICD-10 Finland
Unspecified privation
4.5
10.7
37
85
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.0
10.7
41
104
DQB30
NOMESCO Finland
Laryngectomy
60.5
10.6
12
*
U53
ICPC
Urological, Instrument/catheter/intubate/dilate
60.5
10.6
12
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.6
10.6
77
305
N35.9
ICD-10 Finland
Urethral stricture, unspecified
4.8
10.6
34
72
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.1
10.5
57
190
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.3
10.5
38
91
G82.2
ICD-10 Finland
Paraplegia, unspecified
14.3
10.5
17
12
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
10.5
100
461
N06AX21
ATC
duloxetine; oral
2.2
10.5
105
496
N21.0
ICD-10 Finland
Calculus in bladder
4.8
10.5
34
73
L01BC59
ATC
trifluridine, combinations; systemic
110.8
10.4
11
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
110.8
10.4
11
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
110.8
10.4
11
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
10.4
77
312
Y96.9
ICD-10 Finland
Unspecified type of accident
5.0
10.4
32
65
SPAT1211
SPAT
Application of soft bandage
2.1
10.4
115
566
WW200
SPAT
NA
0.3
10.3
17
620
XG466
NOMESCO Finland
Sleep oxymetry
3.0
10.3
57
193
A10AE04
ATC
insulin glargine; parenteral
2.1
10.3
117
582
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.8
10.3
33
70
N99.1
ICD-10 Finland
Postprocedural urethral stricture
8.9
10.3
21
24
UJD02
NOMESCO Finland
Gastroscopy
2.7
10.3
70
271
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
23.6
10.2
14
6
A07EC02
ATC
mesalazine; oral, rectal
2.7
10.2
71
275
JKA20
NOMESCO Finland
Cholecystectomy
3.4
10.2
49
150
Z08
ICPC
Social welfare problem
7.5
10.2
23
31
N30.2
ICD-10 Finland
Other chronic cystitis
7.5
10.2
23
31
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
10.2
192
1154
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
13.2
10.2
17
13
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
10.1
90
401
E0000UV
ATC
NA
1.5
10.1
415
3069
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
7.0
10.1
24
35
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.6
10.1
45
130
TKD00
NOMESCO Finland
Dilatation of urethra
8.5
10.1
21
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
10.1
504
3894
SPAT1172
SPAT
Guidance concerning hydration
4.0
10.1
39
100
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.1
10.0
19
19
A79
ICPC
Malignancy NOS
7.3
10.0
23
32
D12
ICPC
Constipation
3.3
10.0
49
153
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.8
9.9
63
233
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
4.2
9.9
36
87
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
6.4
9.9
25
40
C07AB07
ATC
bisoprolol; oral
1.5
9.8
562
4460
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
26.2
9.8
13
5
EBA00
NOMESCO Finland
Extraction of tooth
1.6
9.8
344
2452
UDQ02
NOMESCO Finland
Direct laryngoscopy
7.1
9.8
23
33
G41.9
ICD-10 Finland
Status epilepticus, unspecified
10.7
9.8
18
17
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
10.7
9.8
18
17
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.1
9.7
51
167
R47.1
ICD-10 Finland
Dysarthria and anarthria
7.4
9.7
22
30
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
9.7
92
423
Z71.9
ICD-10 Finland
Counselling, unspecified
2.6
9.6
71
285
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.6
9.6
42
120
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
9.5
423
3173
KED22
NOMESCO Finland
Transurethral resection of prostate
2.0
9.5
116
595
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.5
9.5
27
50
K51.8
ICD-10 Finland
Other ulcerative colitis
5.5
9.5
27
50
U70
ICPC
Pyelonephritis/pyelitis
7.2
9.5
22
31
N03AF02
ATC
oxcarbazepine; oral
3.4
9.5
45
137
SPAT1359
SPAT
Use of symptom diary
4.0
9.5
36
91
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.6
9.5
67
264
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.8
9.4
38
101
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
100.7
9.4
10
*
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
100.7
9.4
10
*
Z93.8
ICD-10 Finland
Other artificial opening status
100.7
9.4
10
*
K91
ICPC
Cerebrovascular disease
5.2
9.4
28
55
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.4
509
3983
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
17.7
9.4
14
8
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
5.4
9.4
27
51
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
+∞
9.4
9
*
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
+∞
9.4
9
*
Z47.0
ICD-10 Finland
Follow-up care involving removal of fracture plate and other internal fixation device
+∞
9.4
9
*
Z93.9
ICD-10 Finland
Artificial opening status, unspecified
+∞
9.4
9
*
Z02.7
ICD-10 Finland
Issue of medical certificate
2.4
9.4
79
342
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.3
194
1199
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
9.3
205
1289
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
8.7
9.3
19
22
JEA00
NOMESCO Finland
Appendectomy
2.5
9.3
75
317
K50.9
ICD-10 Finland
Crohn disease, unspecified
5.3
9.2
27
52
N05AA02
ATC
levomepromazine; systemic
2.8
9.2
58
214
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.6
9.2
40
114
OAB50
SPAT
NA
5.0
9.1
28
57
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.1
9.1
34
85
R5140
SPAT
NA
11.6
9.1
16
14
N39
ICD-10 Finland
Other disorders of urinary system
11.6
9.1
16
14
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
9.0
284
1964
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
10.1
9.0
17
17
R5130
SPAT
NA
36.9
9.0
11
*
SPAT1138
SPAT
Guidance concerning bowel function
4.9
9.0
28
58
N18.8
ICD-10 Finland
Other chronic renal failure
3.3
9.0
43
132
WW200
NOMESCO Finland
Immunization
3.6
9.0
39
111
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
8.9
92
440
V03AE01
ATC
polystyrene sulfonate; oral
7.5
8.9
20
27
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
5.3
8.9
26
50
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
8.9
325
2326
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.7
8.9
60
231
R32
ICD-10 Finland
Unspecified urinary incontinence
3.7
8.9
37
102
RS121
NOMESCO Finland
NA
8.0
8.9
19
24
G04BD11
ATC
fesoterodine; oral
3.1
8.9
47
156
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
8.8
123
666
EBA10
NOMESCO Finland
Surgical removal of tooth
2.1
8.8
102
512
HMAK
NOMESCO Finland
NA
1.9
8.8
124
671
ZYC03
NOMESCO Finland
Remote contact, text-based
10.8
8.8
16
15
A12AA04
ATC
calcium carbonate; oral
6.0
8.8
23
39
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.2
8.8
84
390
ZX114
NOMESCO Finland
Intramuscular
5.7
8.8
24
43
U72
ICPC
Urethritis
4.7
8.7
28
60
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.7
424
3234
N06AX16
ATC
venlafaxine; oral
1.9
8.7
122
663
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.7
116
619
KCC10
NOMESCO Finland
Cystoprostatectomy
7.7
8.7
19
25
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.0
8.6
49
168
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
11.7
8.6
15
13
J01XE01
ATC
nitrofurantoin; oral
4.8
8.6
27
57
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.0
8.6
33
85
RJ421
NOMESCO Finland
NA
16.4
8.6
13
8
N03AX18
ATC
lacosamide; systemic
10.1
8.5
16
16
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
8.5
76
339
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
20.2
8.5
12
6
UGC02
NOMESCO Finland
Rigid bronchoscopy
20.2
8.5
12
6
UJC02
NOMESCO Finland
Rigid oesophagoscopy
6.0
8.5
22
37
N06AB06
ATC
sertraline; oral
2.1
8.5
97
484
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
8.4
81
375
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.7
8.4
54
202
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
4.7
8.4
27
58
U06
ICPC
Haematuria
3.2
8.4
43
139
G82.4
ICD-10 Finland
Spastic tetraplegia
90.6
8.4
9
*
N81
ICPC
Injury nervous system other
90.6
8.4
9
*
Z47.8
ICD-10 Finland
Other specified orthopaedic follow-up care
90.6
8.4
9
*
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
90.6
8.4
9
*
ABD40
NOMESCO Finland
Implantation of spinal injection device
90.6
8.4
9
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
8.4
44
145
Z01.7
ICD-10 Finland
Laboratory examination
1.9
8.4
125
693
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.1
8.4
31
77
Z29
ICPC
Social problem NOS
4.1
8.4
31
77
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
12.8
8.4
14
11
G04BD07
ATC
tolterodine; oral
2.4
8.4
67
284
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
+∞
8.3
8
*
Z49.2
ICD-10 Finland
Other dialysis
+∞
8.3
8
*
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
+∞
8.3
8
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
8.3
8
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
4.3
8.3
29
68
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
6.3
8.3
21
34
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.3
8.3
40
124
K56.0
ICD-10 Finland
Paralytic ileus
5.3
8.3
24
46
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
5.3
8.3
24
46
D29
ICPC
Digestive symptom/complaint other
4.7
8.3
27
59
RS222
NOMESCO Finland
NA
5.9
8.3
22
38
G12.2
ICD-10 Finland
Motor neuron disease
9.5
8.3
16
17
R5120
NOMESCO Finland
Preparation of an aid
4.0
8.3
31
78
N06AB04
ATC
citalopram; systemic
1.6
8.2
221
1465
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.2
166
1015
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.5
8.2
20
31
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
8.2
35
99
163
Kela drug reimbursment
Abiraterone and enzalutamide
5.2
8.2
24
47
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
7.6
8.2
18
24
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
8.1
46
158
T83.1
ICD-10 Finland
Mechanical complication of other urinary devices and implants
33.5
8.1
10
*
369
Kela drug reimbursment
Regorafenib
33.5
8.1
10
*
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
17.3
8.1
12
7
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
17.3
8.1
12
7
JD1AB
NOMESCO Finland
Gastro-duodenography with X-ray
17.3
8.1
12
7
JFB50
NOMESCO Finland
Other resection of colon
17.3
8.1
12
7
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.3
8.1
69
304
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.8
8.1
32
85
ZXD35
NOMESCO Finland
Usual procedure
3.1
8.1
43
144
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
9.0
8.0
16
18
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
22.2
8.0
11
5
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
22.2
8.0
11
5
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.6
8.0
22
40
KED33
NOMESCO Finland
Transurethral incision of prostate
3.7
8.0
33
91
N05CD07
ATC
temazepam; oral
1.7
8.0
156
947
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.0
7.9
24
49
J01FF01
ATC
clindamycin; systemic
1.5
7.9
277
1959
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
6.6
7.9
19
29
WX707
NOMESCO Finland
Fiberoscopic intubation
13.1
7.9
13
10
UKD02
NOMESCO Finland
Urethroscopy
7.8
7.9
17
22
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.2
7.9
39
124
A07EA02
ATC
hydrocortisone; rectal
3.4
7.9
36
108
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.8
7.8
21
37
RS220
NOMESCO Finland
NA
5.8
7.8
21
37
JN4AD
NOMESCO Finland
Body CT examination
2.0
7.8
91
461
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
7.8
86
425
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.0
7.8
18
26
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
7.0
7.8
18
26
N06AB10
ATC
escitalopram; oral
1.7
7.7
170
1067
N03AX09
ATC
lamotrigine; oral
2.9
7.7
45
159
R03BB04
ATC
tiotropium bromide; inhalant
1.8
7.7
137
804
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
15.1
7.7
12
8
EDB00
NOMESCO Finland
Partial excision of mandible
45.2
7.7
9
*
M05BX04
ATC
denosumab; parenteral
2.6
7.7
53
207
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
7.7
66
291
R1260
NOMESCO Finland
Evaluation of communicative skills
3.9
7.7
30
79
SPAT1251
SPAT
Organisation of medication
2.6
7.6
54
216
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
18.5
7.6
11
6
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
3.6
7.6
32
90
JAH33
NOMESCO Finland
Opening of laparostomy
25.2
7.6
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
7.6
62
267
ZX136
NOMESCO Finland
Intravesicalis
6.2
7.5
19
31
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.9
7.5
15
17
EB1WA
NOMESCO Finland
NA
10.1
7.5
14
14
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
7.5
60
256
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
7.5
296
2148
R52.2
ICD-10 Finland
Other chronic pain
3.1
7.5
39
129
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
7.5
104
561
D18
ICPC
Change in faeces/bowel movements
3.4
7.5
34
102
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
7.4
128
747
Z93.4
ICD-10 Finland
Other artificial openings of gastrointestinal tract status
80.5
7.4
8
*
SPAT1269
SPAT
Other puncture and/or drainage
7.7
7.4
16
21
PLAK2
NOMESCO Finland
NA
7.7
7.4
16
21
RJ411
NOMESCO Finland
NA
13.4
7.4
12
9
JJB10
NOMESCO Finland
Atypcal resection of liver
13.4
7.4
12
9
K62.4
ICD-10 Finland
Stenosis of anus and rectum
13.4
7.4
12
9
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
6.0
7.4
19
32
UDQ22
NOMESCO Finland
Microlaryngoscopy
5.6
7.4
20
36
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.4
92
480
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
3.0
7.3
40
137
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
8.4
7.3
15
18
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
8.4
7.3
15
18
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.5
7.3
32
93
J01MA06
ATC
norfloxacin; oral
1.7
7.3
140
843
Z45.9
ICD-10 Finland
Adjustment and management of unspecified implanted device
+∞
7.3
7
*
JFB61
NOMESCO Finland
Laparoscopic resection of sigmoid colon with end colostomy and closure of distal stump
+∞
7.3
7
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
7.3
7
*
G04BD12
ATC
mirabegron; oral
1.8
7.3
116
659
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
5.0
7.3
22
45
JHA00
NOMESCO Finland
Anal or perianal incision
5.0
7.3
22
45
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
5.0
7.3
22
45
ZXA10
NOMESCO Finland
Bilateral
1.6
7.3
200
1333
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
7.3
39
132
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
7.3
58
248
R35
ICD-10 Finland
Polyuria
2.1
7.2
82
410
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.2
251
1770
RS221
NOMESCO Finland
NA
4.3
7.2
25
59
Z48.8
ICD-10 Finland
Other specified surgical follow-up care
15.8
7.2
11
7
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.2
7.2
36
116
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
7.2
77
375
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.7
7.2
29
79
M79.6
ICD-10 Finland
Pain in limb
1.5
7.2
340
2560
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
7.2
67
306
QBG00
NOMESCO Finland
Debridement of bedsore of trunk
30.2
7.1
9
*
V03AG01
ATC
sodium cellulose phosphate; systemic
30.2
7.1
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.1
84
428
ZX110
NOMESCO Finland
Intracutaneous
20.1
7.1
10
5
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
20.1
7.1
10
5
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
3.1
7.1
36
117
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.6
7.1
50
199
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
8.0
7.1
15
19
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
8.0
7.1
15
19
RK110
NOMESCO Finland
NA
8.0
7.1
15
19
G72.8
ICD-10 Finland
Other specified myopathies
3.8
7.1
28
75
J01DC02
ATC
cefuroxime; systemic
2.4
7.1
59
257
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.1
7.0
13
13
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
4.2
7.0
25
61
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.0
7.0
16
23
G72.9
ICD-10 Finland
Myopathy, unspecified
7.0
7.0
16
23
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
7.0
7.0
16
23
G91.0
ICD-10 Finland
Communicating hydrocephalus
7.0
7.0
16
23
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.4
7.0
55
231
R40.2
ICD-10 Finland
Coma, unspecified
4.9
7.0
21
43
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.5
7.0
23
52
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
6.4
6.9
17
27
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.4
6.9
31
92
L02BB04
ATC
enzalutamide; oral
5.5
6.9
19
35
ZY000
NOMESCO Finland
Hospital inpatient
5.9
6.9
18
31
AAF00
NOMESCO Finland
Ventriculostomy
5.9
6.9
18
31
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.1
6.8
35
115
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
8.3
6.8
14
17
A07AA02
ATC
nystatin; oral
2.1
6.8
75
372
J86.9
ICD-10 Finland
Pyothorax without fistula
6.7
6.8
16
24
C08CA01
ATC
amlodipine; oral
1.4
6.8
408
3202
ZZR30
NOMESCO Finland
Flap of muscle
11.0
6.8
12
11
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
9.4
6.8
13
14
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
9.4
6.8
13
14
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
4.5
6.8
22
49
K62.6
ICD-10 Finland
Ulcer of anus and rectum
6.1
6.8
17
28
G04BD09
ATC
trospium; oral
3.1
6.8
35
116
G82.0
ICD-10 Finland
Flaccid paraplegia
40.2
6.8
8
*
X77
ICPC
Malignant neopl genital female other
40.2
6.8
8
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
40.2
6.8
8
*
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
40.2
6.8
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
16.8
6.7
10
6
ZX199
NOMESCO Finland
Other rote
16.8
6.7
10
6
OAB42
SPAT
NA
0.1
6.7
*
249
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
6.7
245
1745
SPAT1236
SPAT
Informing family of child’s disability
3.2
6.7
33
106
GBA00
NOMESCO Finland
Tracheotomy
22.6
6.7
9
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
22.6
6.7
9
*
176
Kela drug reimbursment
Regorafenib
22.6
6.7
9
*
N17.8
ICD-10 Finland
Other acute renal failure
4.9
6.7
20
41
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.9
6.7
20
41
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.6
354
2720
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
6.5
6.6
16
25
FM2CE
NOMESCO Finland
NA
7.8
6.6
14
18
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.6
6.6
44
171
A02BC05
ATC
esomeprazole; systemic
1.4
6.6
403
3172
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.8
6.6
26
70
W19
ICD-10 Finland
Unspecified fall
1.8
6.6
103
583
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
12.3
6.6
11
9
K11.70
ICD-10 Finland
Hypoptyalism
12.3
6.6
11
9
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
12.3
6.6
11
9
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.4
6.6
30
91
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.0
6.6
35
119
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
4.4
6.5
22
51
SPAT1260
SPAT
Consultation of another employee
1.6
6.5
192
1298
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
10.1
6.5
12
12
Z93
ICD-10 Finland
Artificial opening status
10.1
6.5
12
12
B02AA02
ATC
tranexamic acid; systemic
1.7
6.5
120
717
WX110
NOMESCO Finland
Local anesthesy
1.4
6.5
679
5838
U14
ICPC
Kidney symptom/complaint
4.5
6.5
21
47
SPAT1111
SPAT
Planning of analgesia
5.4
6.5
18
34
N04AA02
ATC
biperiden; systemic
3.2
6.4
31
98
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.2
6.4
60
276
RF420
NOMESCO Finland
NA
4.3
6.4
22
52
T18.2
ICD-10 Finland
Foreign body in stomach
70.1
6.4
7
*
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
70.1
6.4
7
*
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
70.1
6.4
7
*
Y84.6
ICD-10 Finland
Urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
70.1
6.4
7
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
7.4
6.4
14
19
SPAT1110
SPAT
Measurement of pain intensity
7.4
6.4
14
19
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
7.4
6.4
14
19
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.3
6.4
30
93
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
6.4
34
116
S06.2
ICD-10 Finland
Diffuse brain injury
5.2
6.3
18
35
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.2
6.3
22
53
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
3.5
6.3
27
78
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
11.1
6.3
11
10
RJ410
NOMESCO Finland
NA
11.1
6.3
11
10
N32.1
ICD-10 Finland
Vesicointestinal fistula
11.1
6.3
11
10
RF120
NOMESCO Finland
NA
4.6
6.3
20
44
I95.9
ICD-10 Finland
Hypotension, unspecified
3.7
6.3
25
68
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
6.3
299
2244
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
3.9
6.3
24
63
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.3
295
2209
JFF30
NOMESCO Finland
Other colostomy
18.1
6.3
9
5
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
18.1
6.3
9
5
W17
ICD-10 Finland
Other fall from one level to another
2.4
6.3
49
209
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
+∞
6.3
6
*
AAK80
NOMESCO Finland
Partial excision of skull cap
+∞
6.3
6
*
3591A
ICD-9 Finland
Muscular dystrophies and other myopathies, Hereditary progressive muscular dystrophy
+∞
6.3
6
*
GBC03
NOMESCO Finland
Resection of trachea
+∞
6.3
6
*
ENB20
NOMESCO Finland
Pharyngectomy
+∞
6.3
6
*
GBB18
NOMESCO Finland
Closure of tracheostomy
+∞
6.3
6
*
JCB00
NOMESCO Finland
Oesophagostomy
+∞
6.3
6
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
6.3
6
*
N07BC02
ATC
methadone; systemic
26.8
6.2
8
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
26.8
6.2
8
*
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
26.8
6.2
8
*
E87.5
ICD-10 Finland
Hyperkalaemia
3.5
6.2
27
79
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.9
6.2
34
118
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
6.2
18
36
A08
ICPC
Swelling
2.5
6.2
44
177
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.8
6.2
36
129
A01
ICPC
Pain general/multiple sites
2.0
6.1
80
422
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.1
182
1234
S72.4
ICD-10 Finland
Fracture of lower end of femur
7.7
6.1
13
17
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
7.7
6.1
13
17
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.5
6.1
26
75
N05AA01
ATC
chlorpromazine; systemic, rectal
4.1
6.1
22
55
JFF26
NOMESCO Finland
Sigmoidostomy
8.6
6.1
12
14
RF410
NOMESCO Finland
NA
4.4
6.0
20
46
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
10.1
6.0
11
11
N35.8
ICD-10 Finland
Other urethral stricture
10.1
6.0
11
11
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
10.1
6.0
11
11
S06.0
ICD-10 Finland
Concussion
1.8
6.0
107
631
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.5
6.0
26
76
G04AA01
ATC
NA
5.2
6.0
17
33
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.0
130
814
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
797
3090
4.57
177.90
7.9
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
795
3139
4.45
171.56
7.3
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
432
1200
4.73
145.53
2.9
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
395
1057
4.78
138.88
6.0
3.9
ug/l
37.4
20.9
0.41
333
874
(3026782) Osmolality of Urine
587
2192
3.85
129.50
5.3
2.5
mosm/kgh2o
505.1
566.1
10.60
534
1846
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
370
1005
4.62
126.66
2.8
2.3
g/l
0.2
0.2
0.33
350
932
(3024561) Albumin [Mass/volume] in Serum or Plasma
922
4714
3.69
123.13
8.6
4.3
g/l
32.1
35.5
46.37
881
4350
(3012095) Magnesium [Moles/volume] in Serum or Plasma
476
1623
3.90
118.55
6.8
3.1
mmol/l
0.8
0.8
8.29
449
1519
(3014576) Chloride [Moles/volume] in Serum or Plasma
432
1449
3.84
109.12
11.4
6.8
mmol/l
104.1
104.4
0.55
432
1413
(3021589) Normoblasts [#/volume] in Blood
877
4695
3.25
101.41
18.4
9.2
e9/l
0.0
0.0
0.31
793
3784
(3002582) Erythrocytes [#/volume] in Urine
708
3354
3.20
101.21
7.2
3.1
e6/l
87.5
75.0
0.25
625
2607
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
797
4062
3.18
99.94
6.9
3.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
970
5590
3.29
97.13
10.3
5.6
umol/l
9.9
12.1
9.54
945
5272
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
280
755
4.37
94.84
2.1
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
411
1468
3.53
92.65
2.9
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
250
630
4.60
92.28
1.8
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
400
1419
3.53
90.95
9.2
4.3
mmol/l
1.1
1.0
2.50
375
1299
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
875
4949
2.98
86.72
5.5
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
838
4646
2.94
85.93
10.3
9.4
inr
1.2
1.3
3.23
325
1248
(3018095) Leukocytes [#/volume] in Urine
742
3856
2.92
85.92
9.0
3.5
e6/l
190.2
111.6
1.81
632
2807
(3030467) Casts [#/volume] in Urine by Automated count
639
3076
2.95
85.18
6.8
3.1
e6/l
0.6
0.4
1.39
569
2355
(3020779) Urea [Moles/volume] in Serum or Plasma
308
969
3.78
83.44
10.0
4.8
mmol/l
9.5
9.8
0.34
294
908
(3000850) Epithelial cells [#/volume] in Urine
536
2401
2.97
80.69
4.6
2.5
e6/l
5.6
4.7
0.90
467
2131
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
432
1731
3.14
79.07
6.5
2.9
e6/l
2.1
1.6
1.13
329
951
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
360
1323
3.30
75.92
10.4
7.3
kpa
5.2
5.1
0.67
345
1271
(3027801) Oxygen [Partial pressure] in Arterial blood
360
1324
3.30
75.82
10.4
7.3
kpa
12.7
12.0
1.44
345
1269
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
910
5508
2.80
74.92
12.9
5.8
mmol/l
1.2
1.2
4.05
823
4620
(3014111) Lactate [Moles/volume] in Serum or Plasma
304
1014
3.54
74.78
9.6
7.4
mmol/l
1.2
1.4
3.48
271
975
(36304419) Bacteria [Presence] in Urine
602
3004
2.73
72.18
6.8
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
353
1327
3.20
71.24
10.5
7.3
mmol/l
1.1
1.1
0.04
291
1047
(3013826) Glucose [Moles/volume] in Serum or Plasma
1005
6498
2.84
71.00
8.6
4.6
mmol/l
6.9
6.8
0.38
990
6095
(3022948) Iron [Moles/volume] in Serum or Plasma
405
1655
3.02
70.62
3.2
2.1
umol/l
10.6
13.4
11.33
374
1517
(3044640) Blood type and Crossmatch panel - Blood
641
3335
2.67
70.23
4.7
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
635
3306
2.66
69.24
3.1
2.4
u/l
55.1
57.6
0.70
601
3009
(3004789) Transferrin [Mass/volume] in Serum or Plasma
380
1521
3.04
68.51
3.2
2.0
g/l
2.3
2.3
0.27
357
1403
(3033658) Prothrombin time (PT) actual/Normal
555
2716
2.71
68.41
8.6
3.9
%
86.0
86.1
0.01
547
2651
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
364
1435
3.06
67.28
3.3
2.0
%
19.5
23.7
5.90
329
1212
(3013650) Neutrophils [#/volume] in Blood by Automated count
947
6087
2.65
65.07
15.5
8.2
e9/l
4.6
4.2
4.96
875
5200
(3025159) Blasts/100 leukocytes in Blood
241
754
3.64
64.80
5.5
4.5
%
0.0
0.5
0.54
59
199
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
211
604
3.93
64.60
11.3
10.0
mmol/l
24.4
24.5
0.11
202
558
(3021440) Promyelocytes/100 leukocytes in Blood
248
801
3.54
63.45
5.5
4.5
%
0.2
0.1
0.65
64
238
(3017181) Myelocytes/100 leukocytes in Blood
256
845
3.47
63.31
5.4
4.4
%
0.7
0.8
0.07
66
261
(3000991) Gas panel - Venous blood
280
989
3.28
62.00
13.5
8.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
131
271
5.22
60.53
1.9
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
150
355
4.60
59.00
5.0
4.3
u/ml
0.3
0.4
1.17
80
203
(3021447) Carbon dioxide [Partial pressure] in Venous blood
288
1066
3.13
58.71
6.6
3.4
kpa
6.0
5.8
1.43
270
1030
(3016502) Oxygen saturation in Arterial blood
309
1209
2.99
57.00
11.2
7.6
%
95.2
95.5
0.25
297
1173
(3024354) Oxygen [Partial pressure] in Venous blood
252
886
3.24
55.85
5.7
3.3
kpa
4.9
4.5
1.67
233
855
(3002179) Metamyelocytes/100 leukocytes in Blood
229
761
3.39
55.63
4.8
4.3
%
1.0
0.5
0.58
46
187
(3022217) INR in Platelet poor plasma by Coagulation assay
357
1529
2.78
55.51
23.0
28.0
inr
1.4
1.5
0.20
28
198
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1143
8385
2.81
54.75
13.0
6.7
u/l
89.7
78.6
9.76
1106
7815
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
258
952
3.09
52.47
2.5
2.3
u/l
30.2
37.1
1.25
233
816
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
129
300
4.63
51.72
1.4
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
182
547
3.67
51.46
7.4
4.0
mmol/l
23.9
24.3
0.81
167
487
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
798
5091
2.29
50.30
12.1
5.4
mmol/l
1.2
1.2
6.64
752
4574
(3021901) Oxygen saturation in Capillary blood
103
204
5.36
49.84
4.3
2.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
506
2673
2.38
49.84
10.9
6.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
104
210
5.26
49.24
2.6
3.0
u/ml
54.2
60.8
0.09
97
194
(3002173) Hemoglobin [Mass/volume] in Arterial blood
276
1101
2.87
48.52
12.2
7.8
g/l
115.7
122.9
6.99
270
1073
(3002032) Base excess in Venous blood by calculation
269
1067
2.87
47.74
6.9
3.4
mmol/l
1.9
2.0
0.04
216
826
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
386
1844
2.50
47.13
2.5
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
486
2585
2.33
46.52
4.0
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
278
1142
2.78
46.06
1.6
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
300
1282
2.70
46.02
2.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
299
1278
2.69
45.83
2.4
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
39
28
14.29
42.61
2.3
2.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
125
331
4.04
42.16
10.6
3.6
kpa
9.0
8.5
0.77
119
299
(3035350) Ketones [Presence] in Urine by Test strip
785
5220
2.12
41.54
6.1
3.5
estimate
0.0
0.0
0.00
242
926
(3015377) Calcium [Moles/volume] in Serum or Plasma
601
3615
2.14
41.42
4.7
2.9
mmol/l
2.3
2.4
3.37
549
3103
(3029937) Albumin [Presence] in Urine by Test strip
518
2943
2.19
41.30
6.6
3.9
estimate
0.0
0.0
0.69
235
888
(3022096) Basophils/100 leukocytes in Blood
730
4757
2.09
40.38
8.6
6.0
%
0.6
0.7
6.37
695
4397
(3021601) Nitrite [Presence] in Urine by Test strip
781
5222
2.09
40.26
7.7
4.6
estimate
0.0
0.0
0.50
252
940
(3015235) Bicarbonate [Moles/volume] in Capillary blood
115
298
4.11
39.92
4.6
2.9
mmol/l
24.5
24.9
0.36
102
259
(3009261) Glucose [Presence] in Urine by Test strip
787
5298
2.08
39.58
6.2
3.5
estimate
0.0
0.0
0.80
263
884
(3006504) Eosinophils/100 leukocytes in Blood
743
4911
2.07
39.12
8.5
6.0
%
2.6
3.0
4.55
708
4540
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
268
1168
2.59
38.99
3.3
3.0
umol/l
6.7
8.4
0.86
228
1021
(3019069) Monocytes/100 leukocytes in Blood
744
4940
2.06
38.45
8.7
6.3
%
8.7
8.9
0.81
706
4592
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
99
239
4.38
37.70
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
99
239
4.38
37.70
1.6
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
494
2840
2.13
37.48
2.9
2.2
mg/l
3.5
3.0
3.91
431
2393
(3001604) Monocytes [#/volume] in Blood
772
5254
2.02
36.59
8.4
5.7
e9/l
0.6
0.6
2.40
696
4417
(3006315) Basophils [#/volume] in Blood
773
5270
2.02
36.37
8.6
5.8
e9/l
0.0
0.0
1.16
697
4436
(3002030) Lymphocytes/100 leukocytes in Blood
747
5035
2.01
36.27
8.7
6.1
%
22.5
27.6
27.86
706
4657
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
366
1893
2.25
36.04
6.1
2.7
e6/l
1.5
1.0
0.89
258
1109
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
128
387
3.53
35.54
2.5
2.2
ug/l
229.6
710.7
1.85
120
366
(3018010) Neutrophils/100 leukocytes in Blood
736
4969
1.99
35.20
8.4
5.8
%
61.6
57.1
18.09
701
4617
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
98
249
4.15
34.88
9.3
5.8
mg/l
1.5
1.4
0.69
93
222
(3019198) Lymphocytes [#/volume] in Blood
779
5378
1.99
34.77
8.6
5.8
e9/l
1.6
2.0
6.27
704
4620
(3013115) Eosinophils [#/volume] in Blood
785
5434
1.99
34.77
8.7
6.0
e9/l
0.2
0.2
0.56
710
4666
(4035726)
206
835
2.71
34.42
1.6
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
95
243
4.12
33.50
6.3
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
201
820
2.69
33.10
9.2
3.5
kpa
5.2
5.1
0.67
192
743
(3001122) Ferritin [Mass/volume] in Serum or Plasma
650
4281
1.95
32.62
3.8
2.5
ug/l
153.4
145.7
0.30
606
3890
(3041096) Erythrocytes [Presence] in Urine by Automated
462
2710
2.04
32.29
5.3
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
981
7438
2.02
32.28
7.7
4.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
91
233
4.10
32.03
3.4
2.4
%
17.4
16.3
1.48
75
121
(3009343) pH of Capillary blood
195
814
2.62
30.56
9.3
3.5
ph
7.4
7.4
0.12
24
87
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
201
864
2.54
29.61
5.9
2.9
mmol/l
1.2
1.2
0.09
189
733
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
63
130
5.02
29.01
9.6
6.5
mg/l
11.9
11.8
0.06
58
120
(3049717) Cytology report of Urine Cyto stain
146
542
2.89
28.64
3.0
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
640
4347
1.86
27.88
4.5
3.7
ng/l
67.3
68.2
0.02
514
3225
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
154
606
2.73
27.02
13.4
10.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
127
453
2.98
26.74
2.8
1.8
ug/l
2.3
2.4
0.03
111
400
(3003694) ABO and Rh group [Type] in Blood
451
2780
1.91
26.29
1.4
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
97
300
3.40
25.91
2.8
3.4
g/l
4.1
3.5
2.02
97
290
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
180
784
2.48
25.63
9.4
3.5
mmol/l
2.9
1.8
3.01
129
570
(3003181) Sodium [Moles/volume] in Urine
75
197
3.96
25.48
2.8
1.3
mmol/l
62.9
65.0
0.13
58
156
(3024928) Oxygen saturation in Venous blood
78
214
3.80
24.93
2.7
4.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
94
293
3.36
24.79
5.8
3.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
35
48
7.45
24.24
3.8
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
593
4058
1.79
24.22
6.6
3.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
495
3222
1.82
23.81
4.0
3.2
u/l
32.2
34.4
0.73
473
3046
(42870588) Differential panel, method unspecified - Blood
546
3662
1.79
23.75
7.9
5.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
602
4161
1.77
23.58
3.1
2.1
nmol/l
77.4
77.2
0.07
554
3635
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1243
10730
2.22
22.96
41.8
13.5
mg/l
32.1
26.3
8.45
1192
8406
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
241
1243
2.13
22.90
4.0
4.2
u/l
231.3
246.5
0.84
224
1172
(3023183) Ammonium ion [Moles/volume] in Plasma
82
247
3.46
22.81
2.5
2.9
umol/l
31.2
36.4
1.37
74
211
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
28
9.44
21.79
6.0
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
223
1138
2.14
21.71
5.5
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
519
3500
1.76
21.69
3.7
2.9
ng/l
1959.9
1416.3
1.62
466
3020
(3036481) Cortisol [Moles/volume] in Serum or Plasma
189
905
2.25
21.56
2.6
2.3
nmol/l
377.5
367.5
0.26
171
820
(3000034) Microalbumin [Mass/volume] in Urine
46
96
4.92
20.92
3.7
3.2
mg/l
99.7
19.1
1.31
38
75
(3019309) Folate [Moles/volume] in Red Blood Cells
365
2256
1.83
20.24
2.0
1.8
nmol/l
1389.1
1179.0
3.37
286
1688
(3051651) Icteric interference index of Serum or Plasma
33
53
6.35
19.79
7.4
3.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
125
517
2.55
19.73
1.5
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1050
8714
1.77
19.68
48.9
16.8
%
14.6
13.7
51.43
1042
8496
(3027945) Reticulocytes/100 erythrocytes in Blood
251
1385
1.99
19.64
2.5
2.6
%
1.9
1.7
1.15
221
1227
(3018418) pH of Serum or Plasma
475
3200
1.73
19.46
6.6
3.2
ph
7.4
7.4
3.55
121
588
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
493
3375
1.70
18.94
2.6
2.1
u/l
178.7
268.3
1.66
471
3157
(40760892) CBC W Ordered Manual Differential panel - Blood
350
2179
1.80
18.77
7.1
4.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
28
41
6.95
18.29
2.9
3.8
u/ml
26.3
77.4
0.84
28
41
(3045424) Erythrocytes [Presence] in Urine
58
162
3.69
18.08
2.0
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
416
2.62
17.57
7.7
4.8
%
0.8
0.9
1.61
98
394
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
104
420
2.59
17.23
7.6
4.8
%
1.5
1.7
0.63
98
397
(3019060) Gas panel - Arterial blood
158
772
2.18
17.02
7.4
4.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
569
4135
1.62
16.85
2.6
2.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
115
503
2.40
16.08
6.4
3.2
%
41.7
49.1
1.92
109
496
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
326
2077
1.74
15.81
4.1
2.7
mmol/l
2.5
2.4
8.39
290
1819
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
156
787
2.10
15.45
5.9
3.0
ng/l
103.7
82.0
1.51
141
683
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
191
1042
1.96
15.23
2.9
2.4
ug/l
5.6
6.6
0.44
157
922
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
229
3.02
15.19
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
929
7692
1.59
15.16
4.4
4.0
—
—
—
0
0
(3002256) Pathology report gross observation
239
1413
1.83
14.87
1.3
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
42
108
3.98
14.74
1.3
1.3
mosm/kgh2o
283.4
281.0
0.19
33
75
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
333
2173
1.69
14.67
3.0
1.8
mg/l
1.9
1.4
1.63
276
1678
(3006184) Hemoglobin [Mass/volume] in Capillary blood
71
257
2.85
14.54
2.8
2.2
g/l
134.0
129.8
0.62
62
186
(3051611) Lipemic interference index of Serum or Plasma
38
92
4.22
14.44
7.1
3.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
146
740
2.08
14.26
11.7
6.5
mmol/l
25.0
24.6
0.45
138
693
(3020630) Protein [Mass/volume] in Serum or Plasma
177
962
1.96
14.23
2.4
2.7
g/l
63.5
66.7
4.61
157
880
(3022313) Gas panel - Capillary blood
127
611
2.18
14.18
11.2
3.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
29
58
5.08
13.87
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
63
220
2.95
13.77
1.7
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
138
695
2.09
13.70
2.5
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
73
278
2.71
13.60
1.4
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
48
148
3.32
12.94
2.0
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
181
1024
1.88
12.86
2.3
2.6
e9/l
75.5
67.4
2.25
136
777
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
325
2174
1.64
12.81
4.1
3.8
ng/l
200.2
439.7
2.37
279
1794
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
110
521
2.20
12.77
1.5
1.6
g/l
1.7
1.4
2.49
92
460
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
47
145
3.32
12.66
7.3
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
28
59
4.82
12.63
4.2
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
15
16
9.46
12.56
2.1
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
160
878
1.93
12.47
1.7
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1244
11279
1.80
12.35
45.5
16.3
mmol/l
138.6
139.7
34.31
1230
10960
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
356
2459
1.60
12.24
1.7
1.7
pmol/l
467.9
29877573.3
2.37
311
2035
(3023103) Potassium [Moles/volume] in Serum or Plasma
1244
11313
1.77
11.77
45.4
16.4
mmol/l
4.0
4.0
0.68
1228
10977
(40761511) CBC panel - Blood by Automated count
1224
11135
1.69
10.87
34.3
13.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
87
401
2.25
10.80
3.4
3.2
g/l
0.4
0.3
0.91
45
165
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
95
3.64
10.67
2.7
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
24
52
4.68
10.49
6.1
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
34
5.65
10.24
1.7
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
44
149
3.02
10.21
5.0
4.0
umol/l
350.7
347.0
0.05
38
128
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
53
199
2.73
10.20
1.6
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1121
10044
1.54
9.96
37.5
12.9
ml/min/173m2
79.3
77.6
1.40
1034
8168
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
34
100
3.46
9.90
4.9
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
56
226
2.54
9.37
3.1
1.9
e6/l
1465.2
897.8
0.38
50
178
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
56
226
2.54
9.37
3.0
1.8
e6/l
100.3
48.6
0.38
48
171
(3027273) Bicarbonate [Moles/volume] in Venous blood
106
558
1.97
9.32
5.0
2.7
mmol/l
25.1
25.0
0.16
97
535
(3021960) Folate [Moles/volume] in Serum or Plasma
374
2759
1.48
9.14
1.8
1.5
nmol/l
21.4
20.6
0.50
339
2331
(3023419) Bacteria identified in Sputum by Culture
41
143
2.92
9.06
3.0
2.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
166
1016
1.72
8.99
3.9
2.9
ng/l
257.7
215.7
0.51
151
935
(3020891) Body temperature
96
498
1.99
8.81
9.0
4.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
570
1.93
8.77
1.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
578
4655
1.41
8.68
2.5
2.0
pmol/l
85.8
94.2
5.06
383
2417
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
48
4.43
8.63
1.8
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
167
1038
1.69
8.54
1.7
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
39
137
2.90
8.53
1.3
1.3
e6/l
4427.6
1762.8
0.59
29
99
(3026389) Candida sp identified in Specimen by Organism specific culture
35
116
3.07
8.46
1.8
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
347
2556
1.47
8.45
6.2
3.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
35
118
3.02
8.23
1.3
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
41
152
2.75
8.13
1.2
1.4
g/l
31.7
31.7
0.01
35
138
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
54
231
2.39
8.02
1.5
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
76
1435
0.50
8.00
4.5
4.6
%
33.3
32.5
0.18
42
926
(3023410) Appearance of Cerebral spinal fluid
32
105
3.09
7.88
4.1
2.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
49
203
2.46
7.80
4.1
1.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
13
21
6.24
7.72
1.5
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
129
2.84
7.62
1.3
1.3
e6/l
23223.2
105345.7
0.88
22
77
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
209
2959
0.66
7.25
1.7
1.7
mmol/l
1.5
1.4
1.16
189
2422
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
69
342
2.07
7.21
1.8
2.1
g/l
0.0
0.0
0.18
60
320
(3013707) Erythrocyte sedimentation rate by Westergren method
907
8002
1.37
7.20
4.8
4.0
mm/h
19.0
12.1
20.49
837
7317
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
17
38
4.52
7.18
1.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
190
1273
1.57
7.17
1.8
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
32
112
2.90
7.08
1.5
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
949
10434
0.73
6.93
4.0
4.6
mmol/l
1.4
1.4
4.31
860
9476
(3005570) Glucose [Moles/volume] in Urine
28
92
3.08
6.91
2.8
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
326
2455
1.42
6.90
6.6
3.9
kg/l
1.0
1.0
2.80
43
361
(3045414) Leukocytes [Presence] in Urine
81
434
1.92
6.82
2.4
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
988
10776
0.73
6.64
4.3
5.2
mmol/l
2.5
2.6
8.37
899
9802
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
21
5.75
6.59
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
155
1022
1.58
6.26
6.2
3.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
170
1148
1.55
6.18
3.0
2.5
ug/g
334.9
147.8
3.93
140
912
(3002619) Bacteria identified in Specimen by Culture
11
19
5.83
6.11
1.5
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
32
122
2.66
6.08
1.7
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
692
0.39
6.03
1.3
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
967
10535
0.75
6.00
4.1
4.6
mmol/l
4.3
4.5
8.92
880
9652
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
166
2.39
5.93
1.7
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
21
65
3.26
5.73
3.3
2.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
29
109
2.69
5.68
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
146
2.43
5.57
1.7
1.3
u/ml
111.0
98.1
—
7
23
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
146
2.43
5.57
2.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
172
2.30
5.49
3.5
4.1
%
1.3
1.1
0.12
28
133
(3011648) Oxygen content in Venous blood
24
84
2.89
5.36
2.1
4.8
%
10.0
10.5
0.23
24
84
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
181
2.24
5.32
2.2
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
65
353
1.88
5.31
3.1
3.2
u/ml
1200.9
507.5
0.30
54
297
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
26
4.65
5.26
4.3
2.9
—
—
—
0
0
(3010421) pH of Blood
56
291
1.96
5.22
12.8
3.3
ph
7.4
7.4
0.68
47
238
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1216
11446
1.42
5.20
17.4
10.0
u/l
25.1
26.2
1.17
1180
10951
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
423
1.79
5.15
2.3
2.1
g/l
3.4
3.0
3.85
55
349
(3005719) IgG [Mass/volume] in Serum or Plasma
122
798
1.58
5.12
3.0
2.9
g/l
10.4
10.7
0.26
116
731
(3000494) Fungus identified in Specimen by Culture
179
1273
1.46
5.08
2.1
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
27
104
2.63
5.07
5.6
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
456
1.75
5.03
2.3
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
456
1.75
5.03
2.3
2.1
g/l
7.7
7.3
1.17
55
353
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
456
1.75
5.03
2.3
2.1
g/l
4.2
3.8
1.64
55
340
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
55
3.30
5.03
2.2
1.5
u/l
2.7
9.1
—
9
30
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
69
389
1.81
5.03
1.8
2.2
g/l
0.4
1.4
2.75
60
342
(1761482) Bacteria [#/volume] in Urine by Culture
51
260
2.00
5.02
4.6
3.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
36
160
2.28
5.01
1.8
1.3
u/ml
244.6
255.3
0.10
23
86
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
254
2.00
4.98
2.0
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
60
326
1.88
4.92
1.4
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
48
242
2.02
4.88
14.3
3.5
mmol/l
2.8
2.6
0.14
39
163
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
59
320
1.88
4.86
1.5
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
202
2.11
4.84
6.6
5.1
iu/ml
392.7
608.7
—
9
26
(21494814) CD8 cells/100 lymphocytes in Specimen
12
28
4.31
4.83
4.3
3.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
279
1.93
4.78
1.2
1.4
ug/g
261.6
285.4
0.33
30
175
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
323
1.86
4.73
1.5
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
124
831
1.54
4.69
2.0
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
88
545
1.66
4.63
14.3
3.8
mmol/l
25.7
24.7
1.72
82
503
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
8
10.05
4.52
1.3
7.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
70
2.88
4.50
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
243
1.97
4.48
2.1
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
58
323
1.83
4.43
1.9
2.1
g/l
0.0
0.0
0.00
49
304
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
360
1.78
4.43
1.8
2.0
g/l
34.5
37.9
3.64
54
318
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
143
2.27
4.43
8.8
3.1
u/ml
491.2
338.9
—
6
14
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
82
505
1.66
4.42
3.8
3.5
pmol/l
4.1
4.5
1.82
71
449
(3010813) Leukocytes [#/volume] in Blood
1253
11924
1.41
4.41
53.6
20.5
e9/l
7.4
6.8
11.17
1234
11501
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
150
2.23
4.39
1.9
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
671
0.48
4.37
1.1
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
151
2.21
4.33
1.5
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1252
11921
1.41
4.31
53.4
20.5
e9/l
258.1
242.1
10.78
1236
11545
(3024731) MCV [Entitic volume]
1252
11921
1.41
4.31
53.3
20.4
fl
91.0
91.3
0.94
1241
11694
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
58
326
1.81
4.31
1.9
2.1
g/l
0.0
0.0
0.00
49
305
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
171
2.13
4.31
1.7
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
1252
11922
1.40
4.30
53.2
20.4
pg
29.9
30.4
14.86
1241
11693
(3026361) Erythrocytes [#/volume] in Blood
1252
11923
1.40
4.29
53.5
20.5
e12/l
4.2
4.5
56.78
1231
11502
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
8
9
8.93
4.28
1.3
7.0
mg/l
21.6
20.3
—
8
9
(3000963) Hemoglobin [Mass/volume] in Blood
1252
11925
1.40
4.27
54.0
20.6
g/l
124.4
136.0
100.97
1240
11697
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
193
2.05
4.21
1.9
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
24
97
2.50
4.14
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
110
2.39
4.08
2.5
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
21
80
2.65
4.07
3.4
2.7
—
42.5
—
0
11
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
450
0.39
4.06
1.1
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
30
136
2.23
4.04
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
28
3.95
3.98
1.7
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
31
144
2.18
3.94
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
67
1070
0.61
3.91
1.6
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
11
7.31
3.86
1.8
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
15
6.03
3.82
1.6
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
194
1477
1.36
3.74
1.4
1.2
—
—
—
0
0
(3013512) EKG study
399
3360
1.26
3.65
4.6
3.8
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
45
3.13
3.65
2.8
2.0
umol/l
55.1
51.7
—
9
35
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
942
10094
0.80
3.64
3.9
4.1
mmol/l
1.3
1.3
0.32
855
9103
(3047181) Lactate [Moles/volume] in Blood
57
337
1.72
3.62
10.5
5.9
mmol/l
1.3
1.4
0.08
47
293
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
69
2.63
3.48
3.5
3.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
244
0.32
3.45
1.4
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
53
2.85
3.36
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
53
2.85
3.36
1.2
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
27
3.72
3.35
1.2
1.9
pmol/l
15.3
14.6
—
10
21
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
59
2.73
3.33
1.8
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
282
3411
0.78
3.31
2.5
3.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
94
643
1.49
3.30
1.9
2.0
g/l
1.1
1.7
3.08
87
590
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
249
1.79
3.27
1.7
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
90
2.35
3.25
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
435
1.59
3.22
1.8
2.1
g/l
10.2
10.7
0.52
59
379
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
11
6.39
3.18
1.4
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
85
2.37
3.16
1.2
1.5
nmol/l
0.2
0.3
1.11
12
67
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13
44
2.97
3.14
1.0
1.1
u/l
100.5
21.8
—
6
30
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
13
44
2.97
3.14
1.0
1.1
u/l
222.2
83.8
—
5
30
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
174
1.92
3.06
2.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
45
2.91
3.03
4.6
3.6
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
9
21
4.31
2.99
2.0
2.4
mg/l
6.9
9.2
—
9
21
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
5
10.03
2.98
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
148
1.98
2.96
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
22
4.11
2.88
1.9
2.1
—
—
—
0
0
(44806118)
25
122
2.07
2.88
1.7
1.6
—
—
—
0
0
(44790049)
25
122
2.07
2.88
1.7
1.6
—
—
—
0
0
(44790048)
25
122
2.07
2.88
1.7
1.6
—
—
—
0
0
(44790047)
25
122
2.07
2.88
1.7
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
70
464
1.53
2.88
1.5
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
13
5.41
2.87
1.4
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
358
0.44
2.84
1.3
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
704
0.60
2.84
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
43
701
0.60
2.79
5.2
2.7
—
—
—
0
0
(4062490)
21
97
2.18
2.77
1.7
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
23
3.93
2.77
2.6
1.6
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
6
8.36
2.75
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
72
2.38
2.73
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
69
462
1.52
2.72
2.3
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
79
2.29
2.68
2.6
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
154
1.90
2.67
2.1
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
119
2.03
2.67
3.9
3.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
43
2.81
2.65
1.3
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
7
15
4.68
2.60
2.3
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
107
2.07
2.58
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
717
6571
1.18
2.57
4.2
3.1
u/l
72.2
50.6
3.80
664
6020
(3044007) Cell count panel - Peritoneal fluid
8
20
4.02
2.57
1.0
2.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
49
308
1.61
2.55
2.3
2.4
ug/min
231.4
117.0
0.56
30
195
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
94
2.14
2.55
1.5
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
94
2.14
2.55
1.5
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
94
2.14
2.55
1.5
1.8
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
5
7
7.16
2.55
1.2
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
11
5.47
2.54
1.3
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
56
2.51
2.53
2.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
49
310
1.60
2.49
1.7
1.6
iu/ml
0.1
22.4
0.57
14
60
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
69
2.33
2.48
3.7
3.1
%
9.0
11.7
—
6
38
(4034850)
20
390
0.51
2.46
20.4
10.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
57
2.47
2.45
1.4
1.1
nmol/l
141.3
143.9
0.06
14
57
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
57
2.47
2.45
2.7
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
27
145
1.88
2.42
1.9
1.4
pmol/l
168.8
291.4
0.49
27
145
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
227
1.69
2.41
1.7
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
34
2.95
2.41
1.5
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
12
5.02
2.40
1.3
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
8
6.27
2.37
4.4
4.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
58
2.43
2.37
3.2
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
104
2.03
2.36
1.2
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
12
46
2.62
2.36
1.7
1.2
u/l
34.3
16.4
0.90
12
39
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
17
4.13
2.36
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
148
1.84
2.29
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
423
1.49
2.28
2.3
1.7
—
—
—
0
0
(4027681)
13
53
2.47
2.28
1.1
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
13
4.63
2.27
3.2
2.0
umol/l
19.7
15.4
—
6
13
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
18
3.90
2.25
1.6
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
18
86
2.11
2.23
1.6
1.6
u/ml
31.8
23.3
—
5
18
(4198724)
9
29
3.12
2.22
6.6
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
60
2.35
2.22
1.1
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
139
1096
1.30
2.16
1.7
1.7
%
1.7
1.5
1.66
116
937
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
122
1.90
2.16
1.3
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
14
4.30
2.15
1.7
5.6
—
—
—
0
0
(1002224) Polysomnography panel
17
333
0.50
2.15
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
14
61
2.31
2.15
2.6
1.5
u/field
7.4
3.1
—
7
43
(3007164) IgA [Mass/volume] in Serum or Plasma
230
1929
1.23
2.13
1.5
1.5
g/l
2.6
2.6
0.05
153
1109
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
68
2.22
2.11
2.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
98
738
1.35
2.10
7.1
3.1
e9/l
4.6
4.3
0.54
80
560
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
12
49
2.46
2.10
1.7
1.2
u/l
132.9
101.9
0.35
12
43
(4010399)
56
805
0.68
2.10
1.3
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
54
368
1.49
2.03
2.8
3.4
ratio
19.5
1.6
—
7
23
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1008
10540
0.85
2.03
4.3
4.8
mmol/l
6.1
6.0
0.57
908
9483
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
259
0.46
2.01
4.2
3.5
mg/l
42.1
27.4
—
7
160
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
57
394
1.47
2.00
2.8
2.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
57
2.29
1.98
2.8
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
64
2.20
1.94
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
16
3.76
1.93
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
381
1.46
1.92
2.7
3.4
mg/l
38.2
37.0
0.09
49
315
(3011412) CD3 cells [#/volume] in Blood
18
92
1.97
1.90
3.5
2.7
e9/l
0.9
1.1
0.66
13
52
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
107
1.88
1.86
1.4
1.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.83
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
80
2.01
1.80
1.6
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
23
3.05
1.80
3.3
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
13
60
2.18
1.78
1.2
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
316
3573
0.85
1.76
3.4
3.2
mg/l
646.6
282.0
0.57
224
2339
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
41
2.45
1.75
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
41
2.45
1.75
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
117
1.81
1.74
1.1
1.4
nmol/l
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
18
3.34
1.74
1.7
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
18
3.34
1.74
1.3
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
23
132
1.75
1.74
1.3
1.3
nmol/l
—
0.3
—
0
14
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
381
1.43
1.74
2.8
3.4
mg/l
71.2
52.6
0.56
49
313
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.70
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
126
1.76
1.68
1.3
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
22
126
1.76
1.68
1.3
1.5
pmol/l
230.9
292.2
0.62
16
99
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
126
1.76
1.68
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
119
1.78
1.66
1.4
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
62
2.11
1.65
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
25
2.81
1.65
1.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
83
1.94
1.65
1.1
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
302
1.47
1.64
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
127
1.74
1.64
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
14
3.58
1.61
4.6
2.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
14
3.58
1.61
2.4
2.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
620
5757
1.14
1.61
3.0
2.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
113
1.78
1.61
2.9
2.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
26
2.70
1.58
1.7
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
26
2.70
1.58
2.4
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
33
2.43
1.54
1.1
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
15
3.34
1.52
2.4
2.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
117
949
1.25
1.51
2.4
2.2
nmol/l
8.9
13.2
5.40
99
816
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
1.2
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
128
1546
0.81
1.48
1.2
1.2
u/ml
13.1
12.7
0.03
80
556
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
110
892
1.25
1.44
4.3
2.6
ml/min/173m2
55.2
65.8
2.38
64
366
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
22
2.73
1.43
1.2
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
52
380
1.38
1.42
1.6
1.6
—
162.5
—
0
16
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
247
1.47
1.38
3.3
3.0
nmol/l
0.9
0.8
0.26
29
194
(3050129) First trimester maternal screen panel - Serum or Plasma
5
122
0.41
1.37
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
104
1.74
1.37
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
127
1.66
1.37
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
127
1.66
1.37
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
310
0.61
1.36
1.9
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
15
259
0.57
1.34
1.2
1.1
—
10.0
—
0
22
(3003338) MCHC [Mass/volume]
855
8937
0.89
1.33
48.3
18.4
g/l
328.0
332.7
36.56
848
8857
(3042631) Mycobacterium sp identified in Specimen
23
144
1.61
1.32
3.3
2.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
132
0.45
1.28
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
119
1422
0.82
1.26
1.5
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
2.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
13
70
1.87
1.24
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
13
70
1.87
1.24
1.2
1.2
—
4.8
—
0
14
(3020682) Albumin/Creatinine [Ratio] in Urine
339
3724
0.88
1.23
4.0
4.0
mg/mmol
16.4
8.0
2.67
257
2401
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
45
2.01
1.23
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
71
1.84
1.19
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
26
2.31
1.18
1.3
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
125
1.61
1.18
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
50
2.01
1.16
1.1
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
38
274
1.40
1.16
3.3
3.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
30
207
1.46
1.15
1.1
1.3
—
335.6
—
0
9
(3052592) Norovirus Ag [Presence] in Stool
5
20
2.51
1.15
3.0
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
72
1.81
1.15
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
119
1.60
1.12
2.5
2.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
234
1.42
1.11
2.1
1.4
u/l
20.8
8.5
2.11
26
186
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
73
1.79
1.11
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
290
0.65
1.07
1.1
1.1
—
—
—
0
0
(4024509)
14
82
1.71
1.05
1.5
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
90
1.67
1.04
2.6
1.7
u/field
2.5
2.3
—
6
36
(3026493) Urate [Moles/volume] in Serum or Plasma
317
2895
1.12
1.04
3.0
2.7
umol/l
3079.4
6232.7
0.77
272
2475
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
22
2.28
1.03
1.2
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
140
1615
0.85
1.03
1.2
1.2
iu/ml
23.5
40.0
2.33
45
496
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
60
1.84
1.03
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
188
1.44
1.01
4.7
3.3
e9/l
4.4
4.3
0.03
27
188
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
197
1.43
1.00
6.7
3.6
%
59.3
58.5
0.09
28
197
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
76
1.72
0.99
2.3
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
819
7864
1.10
0.98
4.2
3.6
pmol/l
15.1
14.9
0.83
752
7004
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
31
0.00
0.96
0.0
1.1
—
0.7
—
0
19
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
62
1.78
0.94
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
62
1.78
0.94
1.2
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
146
1276
1.16
0.93
1.3
1.3
titre
377.9
533.9
0.80
29
274
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
27
2.23
0.93
2.7
1.5
mmol/l
1.2
1.2
—
6
27
(3000475) Leukocytes [#/volume] in Synovial fluid
36
269
1.35
0.93
1.7
1.7
e6/l
19925.5
15124.1
0.20
23
195
(36660697) Celiac disease serology panel - Serum
66
807
0.81
0.92
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
70
1.72
0.92
1.5
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
52
1.74
0.92
1.7
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
9
52
1.74
0.92
1.6
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
52
411
1.28
0.91
1.4
1.9
u/l
31.3
40.2
2.30
44
361
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17
255
0.66
0.91
1.4
1.2
—
33.6
—
0
12
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
977
10051
0.91
0.89
6.2
6.1
mmol/mol
41.0
40.4
0.90
911
9195
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
42
1.91
0.88
1.1
1.2
iu/ml
179.1
292.6
—
8
42
(4281824)
13
79
1.65
0.88
1.4
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
62
506
1.24
0.85
5.0
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
171
1530
1.13
0.81
15.5
7.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
24
0.00
0.79
0.0
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
304
0.72
0.78
1.6
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
99
1.52
0.75
5.1
2.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
25
2.00
0.72
1.4
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
39
1.80
0.72
1.0
1.0
miu/ml
2514.7
1612.8
—
7
39
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
1.4
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
1.4
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
1.4
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
56
1.61
0.72
1.4
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
26
194
1.35
0.71
1.3
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
40
1.75
0.71
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.4
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.4
2.2
—
—
—
0
0
(4094501)
22
296
0.74
0.68
1.4
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
69
1.60
0.68
1.1
1.2
u/ml
0.1
0.7
—
5
38
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
42
1.67
0.68
2.1
2.1
—
5708.3
—
0
6
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
42
1.67
0.68
1.6
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
302
1.27
0.68
1.9
1.8
—
—
—
0
0
(3000492) Spirometry study
81
937
0.86
0.67
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
191
0.68
0.67
1.8
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
88
1.48
0.60
1.6
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.2
—
2.0
—
0
20
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
20
0.00
0.60
0.0
3.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.4
—
4.5
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
22
0.00
0.59
0.0
2.2
—
2.7
—
0
7
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
83
946
0.87
0.59
9.4
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
51
604
0.84
0.58
1.5
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
176
1.31
0.56
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
415
4351
0.93
0.55
4.0
4.7
%
19.8
21.8
2.12
203
2264
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
186
1.30
0.54
1.1
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
61
1.48
0.53
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
61
1.48
0.53
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
55
470
1.18
0.53
1.1
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
232
1.26
0.52
1.6
1.6
nmol/l
0.7
0.8
0.37
29
194
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
58
671
0.86
0.52
1.6
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
65
1.39
0.50
1.2
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
65
1.39
0.50
1.6
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
45
1.56
0.49
1.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
589
1.14
0.47
2.9
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
264
1.22
0.46
1.3
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
49
1.43
0.46
11.3
6.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
34
284
1.20
0.44
1.5
1.4
g/l
0.3
0.2
0.97
34
271
(3019832) Treponema pallidum Ab [Presence] in Serum
46
533
0.86
0.44
1.5
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
127
0.71
0.43
1.1
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
21
166
1.27
0.43
1.1
1.1
iu/ml
15.7
91.0
—
9
32
(3002523) Influenza virus A Ag [Presence] in Specimen
9
128
0.70
0.43
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
128
0.70
0.43
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
36
303
1.19
0.43
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.61
0.43
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
4.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
16
0.00
0.41
0.0
5.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
132
1.29
0.40
3.9
5.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
18
0.00
0.40
0.0
7.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
306
1.18
0.40
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
464
0.86
0.40
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
203
0.79
0.38
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
180
0.78
0.37
1.4
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
77
0.65
0.35
1.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
222
0.81
0.34
3.4
2.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
44
1.37
0.34
1.2
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
45
1.33
0.33
1.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
46
1.31
0.33
1.8
1.7
u/ml
687.5
1358.2
—
6
46
(4268621)
6
86
0.70
0.33
2.0
2.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
173
1.22
0.33
1.4
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
47
1.28
0.32
2.0
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
137
1.24
0.32
4.1
3.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
129
0.77
0.28
1.2
1.2
u/ml
1.8
3.8
—
5
44
(3004616) Nuclear Ab [Presence] in Serum
9
118
0.76
0.27
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
56
615
0.91
0.27
1.2
1.3
—
54.1
—
0
26
(3027944) Amphetamines [Presence] in Urine
18
215
0.84
0.27
4.7
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
121
0.74
0.27
1.0
1.1
%
112.9
115.6
—
9
109
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
319
3088
1.04
0.26
3.1
3.2
ug/l
1.0
0.8
0.83
231
2148
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
(4146454)
16
133
1.21
0.24
3.3
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
82
0.73
0.24
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
84
0.71
0.24
1.7
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
223
2146
1.05
0.24
1.2
1.3
u/ml
1.5
1.9
0.31
82
520
(3009542) Hematocrit [Volume Fraction] of Blood
970
9595
1.03
0.23
40.4
15.1
%
36.9
39.7
25.29
662
6358
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
18
153
1.18
0.22
1.1
1.1
g/l
1.6
1.5
0.32
18
144
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
79
1.27
0.22
1.0
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024316) Viscosity of Plasma
0
11
0.00
0.21
0.0
1.3
—
1.7
—
0
6
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
157.5
—
0
11
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
33
296
1.12
0.21
1.5
1.4
g/l
1.2
1.2
0.84
33
279
(3009015) Lactate [Moles/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.5
—
7.3
—
0
7
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
3.1
—
0
12
(3006598) pH of Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
7.2
—
0
12
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
126
1.19
0.21
1.3
1.5
%
85.6
63.3
—
9
84
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.6
1.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(4211845)
6
53
1.13
0.18
2.0
3.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
217
0.87
0.18
4.5
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
217
0.87
0.18
4.4
1.9
—
—
—
0
0
(3019225) pH of Specimen
108
1133
0.95
0.18
5.4
3.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
59
1.19
0.18
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
62
1.13
0.17
1.4
16.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
70
0.71
0.16
1.6
2.0
—
74.9
—
0
13
(3009508) Creatinine [Moles/volume] in Urine
363
3705
0.97
0.16
3.4
3.2
mmol/l
6.6
7.8
5.87
311
3074
(44813793)
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
204
0.88
0.16
4.4
2.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
111
1.17
0.15
2.3
4.1
%
73.0
52.8
—
6
72
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
234
0.90
0.15
1.4
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
213
0.89
0.15
4.4
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
180
0.89
0.13
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
209
0.91
0.11
1.9
1.9
iu/l
2.7
5.1
—
9
73
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
320
0.94
0.09
1.9
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
5.2
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
136
1.10
0.08
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
113
0.88
0.08
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
973
9685
1.01
0.08
4.9
4.4
mu/l
2.1
2.1
0.06
898
8688
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
541
5364
1.01
0.08
5.4
5.3
ug/l
5.9
2.8
2.12
470
4761
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
156
1.09
0.08
3.5
2.0
u/l
955.0
1286.4
—
6
45
(3045142) Bone marrow Pathology biopsy report
14
127
1.10
0.08
1.3
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
74
0.81
0.07
1.8
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
2.0
1.4
—
73.5
—
0
6
(3023511) Choriogonadotropin [Units/volume] in Urine
10
89
1.12
0.07
1.4
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
89
1.12
0.07
1.3
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
183
0.93
0.06
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
131
0.92
0.05
1.2
1.2
u/ml
7.2
5.6
—
5
59
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
535
1.03
0.05
1.1
1.2
iu/ml
92.6
156.9
0.92
18
204
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
249
0.96
0.02
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
142
1.06
0.02
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
57
560
1.02
0.02
1.5
1.3
u/ml
139.8
257.7
1.85
52
516
(21494434) Karyotype in Bone marrow
12
127
0.94
0.01
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
143
1.05
0.01
2.7
2.0
mg/l
22.6
19.4
—
5
36
(4306422)
13
124
1.05
0.00
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
234
1.03
0.00
1.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
124
0.97
0.00
1.6
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
128
1.02
0.00
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
168
1.01
0.00
3.5
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
686
1.01
0.00
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
212
0.99
0.00
1.4
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
109
1.01
0.00
1.5
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
181
0.99
0.00
1.1
1.3
miu/ml
48.6
212.9
—
5
76
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
98
982
1.00
0.00
1.5
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
36
355
1.01
0.00
1.1
1.2
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.0
—
121.8
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.8
—
0
5
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
8.2
—
0
5
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.1
—
0
5
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
157.8
—
0
6
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
3.0
u/l
216.4
206.0
—
5
52
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
54
0.93
0.00
6.8
3.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.3
—
0.9
—
0
7
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
94
0.96
0.00
1.1
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_ATTN_ARTIF_OPENI – Attention to artificial openings
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).